Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 431 (RNA5SP431)

Target
RNA5SP431
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 431 (RNA5SP431) is classified as a pseudogene of the 5S ribosomal RNA (rRNA) gene family[2][4]. Unlike functional 5S rRNA, which is a highly conserved and essential structural component of the large subunit of ribosomes in all domains of life and required for protein synthesis[1][3], pseudogenes like RNA5SP431 are non-functional genomic DNA sequences that resemble functional genes but are not typically transcribed into functional RNA molecules or translated into proteins. The vast majority of 5S rRNA pseudogenes in the human genome do not encode functional RNA and are considered genomic "fossils" without known physiological or disease relevance[7]. There is no evidence that RNA5SP431 functions as a receptor, enzyme, transporter, drug target, or biomarker. Furthermore, there are no known drugs or therapeutic agents that interact with this pseudogene. Therefore, it is not considered a therapeutic or biological target. Key context: - Pseudogenes are defective copies of genes that no longer produce functional products, typically arising from gene duplication or retrotransposition events[4]. - While some pseudogenes can have regulatory or rare functional roles, the majority—including RNA5SP431—lack any demonstrated role in cell biology or disease, drug interaction, or utility in biomarker assays[7][2]. - The inclusion of "RNA, 5S ribosomal..." designates its family origin (ribosomal RNA), but the addition of "pseudogene" and the individual numeric identifier signifies it is not a functional gene product and not a therapeutic target[2][4]. Summary of why this target is marked as "is_incorrect: true," and "is_target: false": - This molecule is a pseudogene, not a receptor, enzyme, or any functional target relevant to pharmacology or experimental therapeutics[2][4]. - There is insufficient or no evidence for drug, biomarker, or disease involvement, and it should not be considered a target by conventional standards.

Other names
RN5S431RNA, 5S ribosomal 431RNA5SP431

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 431 (RNA5SP431).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 431 (RNA5SP431).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call